Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | FLORENCE INDIA | 13 | ₹5,821.50 |
| 2 | Schedule 2 | G K TRADERS | 11 | ₹13,799.94 |
| 3 | Schedule 3 | ALBINO LIFESCIENCES PRIVATE LIMITED | 1 | ₹31,046.40 |
| 4 | Schedule 4 | ALBINO LIFESCIENCES PRIVATE LIMITED | 1 | ₹5.6 L |
| 5 | Schedule 5 | Not yet disclosed by govt. | 23 | - |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
5 Feb 2025, 11:00 amClosed
Vincristine Sulphate 1mg Inj
Cyclophosphamide 500 mg Inj
Ifosfamide Inj 1g vial with 3 amp of 2 ml each Mesna
Tab Dacomitinib 30 mg Bottle of 30 Tab
cabozantinib 40 gm
Tab Cabozantinib 60 mg
Inj Bevacizumab 300mg
Inj Pemetrexed 100 mg
Carboplatin 450mg Inj
Inj Denosumab 120 mg
Inj avelumab 200 mg PER 10ml
Inj Eribulin vial of 1 mg
Etoposide 100mg
5 ml Inj
Pegylated Liposomal Doxorubicin 20mg Inj
Irinotecan 100mg Inj
Gemcitabine 1000mg Inj
Gemcitabine 200mg Inj
INJ TPGS DOCETAXEL 20MG
Docetaxel 80mg PER 2ml vial 6 ml solvent for Inj
Erlotinib 150 mg Tab
Tab Everolimus 10 mg
inj Pegylated GCSF 6mg.
Oxaliplatin 50mg Inj
Goserlin 3.6 mg Prefilled Syringe
Oxaliplatin 100mg Inj
Actinomycin D 0.5 mg Inj
Inj Pegylated Liposomal Irinotecan 4.3mg PER ml
Inj Amivantamab infusion 350mg PER 7ml
inj TPGS Docetaxel 80 mg
inj TPGS Docetaxel 20 mg
Bevacizumab 100 mg SLACE 4ml vial
Inj Bid Number ( ) : GEM/2024/B/5705648 Dated : 15-01-2025 Bid Document 1/32
7247571
GEM/2024/B/5705648
Two Packet Bid
Vincristine Sulphate 1mg Inj
30 days
West Bengal; Kolkata
Item wise evaluation
BOQ
7 documents required · 7 mandatory
2 yrs
₹3
20%
Exempted
5 Feb 2025
15 Jan 2025
5 Feb 2025
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Vincristine Sulphate 1mg Inj | 150 | AMP slace VIAL | Consignee2DGLP | 30 |
| 2 | Cyclophosphamide 500 mg Inj | 462 | AMP slace VIAL | Consignee2DGLP | 30 |
| 3 | Ifosfamide Inj 1g vial with 3 amp of 2 ml each Mesna | 120 | AMP slace VIAL | Consignee2DGLP | 30 |
| 4 | Tab Dacomitinib 30 mg Bottle of 30 Tab | 12 | Bottle | Consignee2DGLP | 30 |
| 5 | cabozantinib 40 gm | 600 | NOS | Consignee2DGLP | 30 |
| 6 | Tab Cabozantinib 60 mg | 600 | NOS | Consignee2DGLP | 30 |
| 7 | Inj Bevacizumab 300mg | 180 | Vial | Consignee2DGLP | 30 |
| 8 | Inj Pemetrexed 100 mg | 60 | Vial | Consignee2DGLP | 30 |
| 9 | Carboplatin 450mg Inj | 600 | AMP slace VIAL | Consignee2DGLP | 30 |
| 10 | Inj Denosumab 120 mg | 90 | Vial | Consignee2DGLP | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7247571.pdf
GEM_BID
atcpdf_2024-12-13-17-59-34_7880028e52dd1d9ef616ad3c22de06d5.pdf
BOQ
boq_item_2024-12-13-17-59-34_fb70172df9ff6a18f6179a291853798f.csv
BOQ
Origin_3d208f98-3054-4fe0-97621734093533477_buyer10chec.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .